Clinical Benefit in Glycemic Control Using a Long-term, Implantable, Continuous Glucose Monitoring System in a 90-Day Feasibility Study

被引：0
|
作者：
Mdingi, Colleen
Rastogi, Ravi
Dehennis, Andrew
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
837-P
引用
收藏
页码：A213 / A214
页数：2
相关论文
共 50 条
  • [1] LONG TERM IMPLANTABLE CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM DEMONSTRATES BENEFITS IN GLYCEMIC CONTROL WITH WEAR COMPLIANCE
    Raisoni, B.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A103 - A103
  • [2] Review of the Long-Term Implantable Senseonics Continuous Glucose Monitoring System and Other Continuous Glucose Monitoring Systems
    Joseph, Jeffrey I.
    [J]. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2021, 15 (01): : 167 - 173
  • [3] FEASIBILITY STUDY USE CASE AND PERFORMANCE OF A 90-DAY IMPLANTABLE CGM SYSTEM
    Chen, X.
    DeHennis, A.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A31 - A31
  • [4] Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring
    Xing, Dongyuan
    Kollman, Craig
    Beck, Roy W.
    Tamborlane, William V.
    Laffel, Lori
    Buckingham, Bruce A.
    Wilson, Darrell M.
    Weinzimer, Stuart
    Fiallo-Scharer, Rosanna
    Ruedy, Katrina J.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (03) : 351 - 358
  • [5] The Long-Term Impact of a Flash Glucose Monitoring System on Glycemic Control
    Fujiya, Atsushi
    Kiyose, Toshiki
    Shibata, Taiga
    Sobajima, Hiroshi
    [J]. DIABETES, 2019, 68
  • [6] Real-World Data from US Patients Using a Long-Term Implantable Continuous Glucose Monitoring (CGM) System: Age Effect on Glycemic Control
    Tweden, Katherine
    Ghosh-Dastidar, Samanwoy
    Dehennis, Andrew D.
    Kaufman, Francine
    [J]. DIABETES, 2020, 69
  • [7] Optimal Periodic Sampling Intervals To:Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring
    Xing, Dongyuan
    [J]. DIABETES, 2009, 58 : A109 - A109
  • [8] Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control
    Riddlesworth, Tonya D.
    Beck, Roy W.
    Gal, Robin L.
    Connor, Crystal G.
    Bergenstal, Richard M.
    Lee, Sooji
    Willi, Steven M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (04) : 314 - 316
  • [9] Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System
    Deiss, Dorothee
    Szadkowska, Agnieszka
    Gordon, Debbie
    Mallipedhi, Akhila
    Schuetz-Fuhrmann, Ingrid
    Aguilera, Eva
    Ringsell, Corina
    De Block, Christophe
    Irace, Concetta
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (05) : 254 - 264
  • [10] INTERIM 365 DAY PERFORMANCE OF A LONG TERM IMPLANTABLE CONTINUOUS GLUCOSE MONITORING SYSTEM WITH REDUCED CALIBRATION
    Sanchez, P.
    Al-Khawi, L.
    Masciotti, J.
    Velvadapu, V.
    Dehennis, A.
    Tweden, K.
    Kaufman, F.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A164 - A164
12345